Background: Population-based measures of admissions among patients with chronic conditions are important quality indicators of Accountable Care Organizations (ACOs), yet there are challenges in developing measures that enable fair comparisons among providers.
(CMS's) Shared Savings Program, providers voluntarily come together to provide efficient, coordinated care for a population of Medicare Fee-for-Service (FFS) beneficiaries. 2 Outcome measures are an important component of such programs, serving to assess whether these new provider arrangements are benefiting patients. Hence, CMS has supported the development and use of new quality outcome measures that focus on population-based admission rates among patients with chronic conditions in the Medicare Shared Savings Program.
Acute hospital admissions are important health outcomes for patients with chronic conditions and serve as useful indicators of the quality of chronic disease management and care coordination. [3] [4] [5] [6] [7] [8] Patients with chronic conditions are susceptible to exacerbations of, and complications from, their underlying disease, and are vulnerable to other acute illnesses, some of which may be averted with highquality care. 3, 9 To assess ACOs' ability to manage complex patients with chronic conditions, we developed 2 outcome measures of acute, unplanned admissions for use in the Shared Savings Program. These measures focus on patients with diabetes and patients with heart failure because these patients are at high risk for hospitalization. Moreover, diabetes and heart failure affect 18% and 14% of Medicare beneficiaries and these patients account for 32% and 43% of Medicare spending, respectively. 10 CMS recently added these measures to the ACO pay-forreporting and pay-for-performance measure set. 11 Other existing ACO outcome measures, such as the Agency for Healthcare Research and Quality Prevention Quality Indicators (PQIs) have been adapted for the ACO program, but are limited. These PQIs are based on admission rates but focus on a narrow outcome (exacerbations of the condition of interest), lack risk adjustment for comorbidities and disease severity, and include planned (as well as unplanned) admissions.
The development of these measures required alignment of methodologic decisions with the Shared Savings Program structure and goals. 2 Specifically, the measures needed to define the outcomes that best reflect quality, adequately risk adjust for case-mix differences across providers, and account for the nested structure of patients within ACOs. 12, 13 In addition, in designing the risk-adjustment strategy, these measures required decisions about which factors may influence admission rates but differ across ACOs; we also needed to consider whether ACOs can be held accountable for such factors in the complex ambulatory care environment. For example, many clinical, behavioral, social, and community factors may affect the risk for admission. Although some of these may be outside of ACOs' scope of influence, the ACO program structure is designed to incentivize providers to think broadly about their ability to improve the health of the people they serve. For all of these methodologic decisions, we sought input from experts and the public, and adhered to guidelines for scientific soundness set forth by the National Quality Forum (NQF).
In this paper we present the methodologic approach to measure development, describe the rationale for key methods decisions, and report model performance and measure score reliability testing. In addition, we report the measure scores [risk-standardized acute admission rates (RSAARs)] for Shared Savings Program ACOs existing in 2012 and evaluate variation in ACO performance relative to the national rate of admissions for all Medicare FFS beneficiaries with diabetes and with heart failure.
METHODS
To develop these measures, we assembled a multidisciplinary team of clinicians, health services researchers, and biostatisticians. In accordance with CMS's standardized, transparent process, we convened a national technical expert panel comprised of patients, health industry representatives, researchers, and health care providers with expertise in diabetes, heart failure, and geriatrics. We also held a public comment period soliciting stakeholder input on the measure methodology, and refined the measure in response to comments. We tested the measures against the NQF's criteria for scientific soundness and importance, 12, 13 including testing the risk-adjustment model properties and evaluating the measure score variation across Shared Savings Program ACOs.
Data Sources
To develop each measure, we assembled Medicare FFS claims data from 2010-2012 linked using unique patient identifiers. To define the cohorts and identify each patient's risk factors, we used 2010-2011 Medicare Part A and Part B claims from the Chronic Conditions Data Warehouse which consists of 100% of FFS patients. We used the 2012 Medicare Provider Analysis and Review 100% FFS dataset of Medicare Part A claims to assess the outcome of admissions.
To determine Medicare FFS enrollment, demographic, and death information, we used Medicare denominator files. CMS provided a data file identifying the 114 Shared Savings Program ACOs that participated in 2012 and beneficiary assignment.
For measure development and testing, we randomly split the full sample into a development and a validation sample for each of the 2 measures. In addition, for measure score reliability testing, we randomly split the full sample into 2 reliability testing samples by randomly splitting each ACO's patients in half and then randomly splitting all non-ACO patients in half.
Measure Cohorts
The target populations for these measures are Medicare FFS patients aged 65 years and above with diabetes or heart failure. We sought to define cohorts inclusive of patients at all stages of diabetes and heart failure while ensuring the measures can fairly balance differences in patient mix across ACOs.
Patients with diabetes had at least 1 inpatient or 2 outpatient claims for diabetes (in any position on the claim) within the 2 years before the measurement period (Appendix Table 1 , Supplemental Digital Content 1, http://links. lww.com/MLR/B141). Patients with heart failure had at least 1 hospital claim with a principal diagnosis code for heart failure or 2 claims (inpatient or outpatient) with codes for heart failure in any position within the 2 years before the measurement period (Appendix Table 2 , Supplemental Digital Content 1, http://links.lww.com/MLR/B141). To adequately assess covariates for risk adjustment, we required continuous enrollment in Medicare Parts A and B during the year before the measurement period (ie, year 2011).
For both measures, we excluded patients without continuous enrollment in Medicare Part A during the measurement period (ie, 2012) to assess the outcome. For the heart failure cohort only, we excluded patients with left ventricular assist devices (LVADs) because they are highrisk patients clustered among a few ACOs.
Outcome
The outcome for both measures was the number of acute, unplanned admissions per 100 person-years at risk for hospitalization. Persons were considered at risk for admission if they were alive, enrolled in FFS Medicare, and not currently admitted. Admissions were defined as any inpatient admission to a short-term acute care hospital for any cause during the measurement year, unless an admission was identified as "planned." To identify planned admissions, we adapted a planned admission algorithm developed for CMS's hospital readmission measures with 2 adaptations: we removed cardiac catheterization and amputation of lower extremity from the planned procedure list as these procedures are frequently unplanned admissions among ambulatory patients with diabetes and heart failure. 14 The outcome was measured over 1 year, consistent with the structure of the ACO program. 2 
Covariates for Risk Adjustment
In designing the risk-adjusted models, we considered several factors that may affect performance on the measures, but not be an indicator of ACO quality. They included: (1) Selection of clinical variables that increase risk of admission: We assessed risk factors in the year before the measurement of the outcome. Some of these risk factors may reflect the quality of chronic disease management over many years, presumably before the ACO assumed care of these patients. Candidate risk variables were selected from 189 diagnostic condition groups included in CMS's Hierarchical Condition Category clinical classification system. 15 Details of candidate variable selection are included in the Appendix (Supplemental Digital Content 1, http://links.lww.com/ MLR/B141). (2) Accounting for patients' disease severity that may vary across ACOs: For the diabetes measure, we used a diabetes complications severity index that has been validated in claims data. 16, 17 The index takes on values from 0 to 7, according to the number of complications present (ie, retinopathy, nephropathy, neuropathy, cerebrovascular, cardiovascular, peripheral vascular disease, and metabolic complications). For the heart failure measure, we considered a history of implantable cardiac defibrillator (ICD), cardiac resynchronization therapy (CRT), or permanent pacemaker (PPM) to identify patients with more advanced disease. Although PPM does not necessarily reflect advanced heart failure, the unadjusted rates of admission were similar for ICD, CRT, and PPM.
(3) Consideration of sociodemographic factors that may impact the rate of admission, including age, sex, race, and socioeconomic status (SES): With the exception of age, we did not adjust for other demographic variables. Differences in the risk for hospitalization among patients of different sociodemographic characteristics may represent disparities in the delivery and quality of care, which we do not want to obscure by including these variables in the risk-adjustment model. Nevertheless, we recognize that there are discordant data with respect to outcomes by sex. [18] [19] [20] In addition, we appreciate the concern that outcome measures may be unfair to ACOs caring for disproportionately low socioeconomic populations. 21, 22 To address these concerns, we tested the impact on measure scores of including sex and SES in the risk-adjustment models. (4) Consideration of other aspects of population health, such as healthy behaviors and community resources: We did not include such factors in the risk-adjustment models; as part of their mission, ACOs are encouraged to influence health behaviors, and to develop strategic partnerships with community-based organizations and businesses, to improve population health and to reduce the risk of admission.
We used the Akaike Information Criterion (AIC) values to select the best-fitting model using the fewest candidate variables; AIC is commonly used in variable selection for negative binomial models (which use count data, such as a count of the number of admissions) to account for overdispersion (whereby data vary more than expected). 23 
Statistical Model
The RSAAR for each ACO was calculated as the number of predicted to the number of expected admissions per 100 person-years, multiplied by the national rate of admissions among all Medicare FFS patients with diabetes or heart failure. The measure uses a 2-step statistical model that accounts for the clustering of patients within ACOs and accommodates the varying sizes of different ACOs. Among models appropriate for use with count data, in this case the number of admissions, we selected a negative binomial model form because it best accounted for overdispersion within the data (more variance in the data than predicted).
The first step of the model (patient level) adjusts for patient risk factors. The relationship between patient risk factors and the outcome of admission is determined based on all patients with diabetes or all patients with heart failure. Because the effects that risk factors exert on the number of admissions are estimated based on data from all patients in the nation, irrespective of whether they are cared for by an ACO, the expected number of admissions for each ACO is determined by all providers and patients nationally. Hence, ACO performance is assessed relative to patients cared for by ACO and non-ACO providers.
The second step of the model is a hierarchical model. This model estimates an ACO-level random-intercept term that reflects the ACO's contribution to admission risk. This ACO-level random effects term is based on the ACO's actual admission rate, the performance of other providers, and the ACO sample size. The model takes into account ACO sample size only insofar that estimates of the ACOlevel random effects term for ACOs of small size are less certain. Therefore, ACOs with few cases are assumed to perform more like average providers.
Analyses
To assess performance of the patient-level model for each measure, we computed 2 summary statistics: (1) goodness-of-fit statistic (deviance R 2 ) and (2) overfitting indices. We randomly split each measure cohort into a development and validation set and calculated deviance R 2 using the model deviance residual 24 and overfitting indices.
To assess the effect of sex and low SES status (defined as Medicare-Medicaid dual eligibility) on model performance, we compared the correlation between measure scores with and without each variable in the models using the Spearman correlation coefficient.
To assess the reliability of ACO scores (ie, to test the measure's ability to assess ACO quality consistently with repeated measures), we randomly sampled half of the patients from each ACO and half of the patients who were not in ACOs, and compared measure scores between the 2 samples. Thus, each ACO was measured twice, but each measurement was made using an entirely distinct set of patients. As a metric of agreement we calculated the intraclass correlation coefficient (ICC). 25, 26 For each ACO, we calculated an interval estimate (IE) using bootstrapping methodology. Using 95% IEs, we assigned ACOs to 1 of 3 performance categories: "better than the national rate," "no different than the national rate," and "worse than the national rate," with "better than" and "worse than" falling below and above the 95% IEs, respectively.
Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC).
RESULTS

Cohorts
For the diabetes measure, after exclusion of patients without continuous enrollment in Medicare Part A in 2012 (n = 225,314), the cohort included 6,521,462 patients. The majority of patients were female (54.7%), average age was 76.4 years, and 341,193 (5.2%) were assigned to one of 114 Shared Savings Program ACOs (Table 1) .
For the heart failure measure, after exclusion of patients without continuous enrollment in Medicare Part A in 2012 and of patients with an LVAD (n = 66,909 and 1048, respectively), the cohort included 2,581,892 patients. The majority of patients were female (56.9%), average age was 80.4 years, and 123,626 (4.8%) were assigned to one of 114 Shared Savings Program ACOs (Table 2 ).
There were no differences in the demographic or clinical factors for the split development and validation samples when compared with the overall samples for the 2 cohorts (data not shown).
Candidate and Final Variables
For each of the measures, the best combination of variables based on AIC was 23 of the 24 candidate variables (see Appendix Tables 3 and 4 , Supplemental Digital Content 1, http://links.lww.com/MLR/B141), all of which were significantly associated with the outcome (P < 0.05). Table 3 shows final model variables and their rate ratios for each measure.
Model Performance
For the diabetes measure, the deviance R 2 in the development and validation samples were 0.217 and 0.218, respectively, and for the heart failure measure were 0.122 and 0.123. These indicate that the models explain B22% and B12% of the variation in admissions across patients with diabetes and heart failure, respectively. Overfitting indices were 0.0017, 1.0031 and À 0.0020, 1.0002 for the diabetes and heart failure measures, respectively; the overfitting index of g 0 close to 0 and g 1 close to 1 indicates good calibration of the models. In addition, the plots of observed and predicted probabilities for each number of hospital admissions (0, 1, 2, y, 10) across 4 risk groups show that the models perform well across a broad range of risk categories (see Appendix Figs. 1, 2 
ACO-level Measure Score Diabetes Measure
In 2012, there were 2,940,537 hospital admissions, with 353,192 (12.0%) classified as planned admissions, resulting in a total of 2,587,345 acute, unplanned admissions.
The crude national Medicare FFS rate of acute, unplanned admissions was 41.4 per 100 person-years. Among ACOs, the mean RSAAR was 39.6 admissions per 100 person-years (SD = 7.3), whereas the median was 39.1 (interquartile range, 34.8-43.9). The minimum, 5th percentile, 95th percentile, and maximum RSAAR scores were 23.9, 28.6, 53.0, and 68.1 admissions per 100 person-years, respectively (Fig. 1A) .
In total, 51 ACOs (44.7%) had RSAARs that were "no different" from the national Medicare FFS rate among patients with diabetes. An additional 45 ACOs (39.5%) had RSAAR scores "better than the national rate" and 18 ACOs (15.8%) "worse than the national rate" (Fig. 2 ).
Heart Failure Measure
In 2012, there were 2,123,190 hospital admissions, with 145,443 (6.9%) classified as planned admissions, resulting in a total of 1,977,747 acute, unplanned admissions.
The crude national Medicare FFS rate of acute, unplanned admissions was 85.5 per 100 person-years. Among ACOs, the mean RSAAR was 81.9 per 100 person-years (SD = 11.6), whereas the median was 81.5 (interquartile range, 73.6-88.8). The minimum, 5th percentile, 95th percentile, and maximum RSAAR scores were 53.7, 64.6, 101.7, and 120.7 admissions per 100 person-years, respectively ( Fig. 1B) .
In total, 61 ACOs (53.5%) had RSAARs that were "no different" from the US national Medicare FFS rate among patients with heart failure. An additional 37 ACOs (32.5%) had RSAAR scores "better than the national rate" and 16 (14.0%) "worse than the national rate" (Fig. 2) .
Measure Score Reliability
The ICC was 0.89 for the diabetes measure and 0.81 for the heart failure measure, which according to the conventional interpretation is considered "almost perfect agreement" between 2 datasets. 26 Thus, the measures reliably assessed ACO quality when calculated based on 2 separate datasets.
Sensitivity Analyses
Comparing the RSAAR with and without sex included in the models resulted in a high degree of correlation in both the diabetes and heart failure measures (Spearman correlation coefficient = 0.999 and 0.999, respectively). Similarly, RSAARs with and without adjustment for Medicaid dualeligibility status were highly correlated for both measures [Spearman correlation coefficient = 0.976 ( Fig. 3A) and 0.991, respectively (Fig. 3B) ]. Hence, the measure scores were very similar whether or not sex or Medicaid dual eligibility was included in the models.
DISCUSSION
We developed 2 population-based, risk-standardized measures of acute hospital admissions for patients with diabetes and patients with heart failure. The measures account for differences in clinical risk profiles of patients cared for by different ACOs (case-mix) and can be used to assess ACO performance. Consistent with the NQF's criteria for scientific soundness and importance, the risk-adjusted models performed well across groups of patients at varying levels of risk for admission and had excellent reliability in the random split sample. Moreover, the measures show that there was significant variation in performance among ACOs within the Shared Savings Program, suggesting opportunities for improvement. For more than a decade we have known that admission rates vary across the country, even after adjusting for differences in patient populations. [27] [28] [29] [30] To date, however, admission rates have been used as quality and accountability measures to only a limited degree. 31 For example, it is only recently that CMS has started to use admission scores developed by the Agency for Healthcare Research and Quality, known as PQIs, in several of its programs. However, these admission rates count only disease-specific admissions (eg, heart failure admissions for heart failure patients) and do not capture the wide spectrum of hospital admissions (eg, admissions related to falls or pneumonia) for which patients with chronic conditions are at increased risk.
As we move toward patient-centered systems of care and away from disease-centered systems of care, it is important to develop outcome measures that reflect the quality of comprehensive, coordinated care for patients with chronic conditions. The measures we developed use a broad outcome of acute, all-cause admissions to capture hospitalizations related to the 2 chronic conditions as well as those that are unrelated. Intentionally, the measures only include unplanned admissions in the outcome because most planned admissions do not represent acute events that could have been prevented by high-quality care.
The 2 measures of acute admissions are particularly suitable for helping ACOs advance their mission of improving quality of care and population health and of reducing cost growth. Diabetes and heart failure are complex, highprevalence chronic conditions that increase the risk for hospital admission. Provision of coordinated care that is focused on improving health for the whole patient, across all stages of disease, and in the context of coexisting comorbidities and life circumstances should lower the risk of hospitalization. Indeed, research shows that effective health care can lower the risk of admission for these vulnerable groups of patients. [3] [4] [5] [6] [7] [8] 32 In addition, providing timely and effective care that reduces the need for admissions is synergistic with the overall goal of ACOs to reduce costs, while maintaining high quality of care. Although these acute admission measures may be applicable for comparing performance among other ambulatory systems of care, the measure specifications need to be vetted with relevant stakeholders.
In developing these outcome measures to assess ACO performance, it was important to identify factors influencing admission which are not markers of ACO quality, including differences in case-mix. This is challenging, as patients with chronic disease accumulate risk over decades. As such, we adjusted for clinical conditions that were present in the year before the start of the measurement period and we included indicators of diabetes and heart failure severity. We did not adjust for sex in these outcome measures. After adjustment for age and clinical factors, any remaining differences in the risk for hospitalization among patients of different sex may represent disparities in care delivery and quality of care. Further, we tested adjustment for sex and found a very high degree of correlation in the measure scores adjusted and unadjusted for sex. This suggests that case-mix difference by sex contributes little to the variation in measure scores across ACOs. We did not adjust for SES given the ACO program design. The ACO program incentivizes providers to broadly address factors affecting health risks. Some of the pathways by which sociodemographic factors may influence admission rates can potentially be affected by ACOs. For example, ACOs can enhance access to care through transportation, expanded hours, and home visits. These measures, unadjusted for SES, will reveal when ACOs are doing exceptionally well with low SES populations. Future research is needed to further examine the socioeconomic characteristics of ACO populations and their association with ACO performance.
Although we tailored our approach to the ACO program, our methods should inform future development of population-based measures designed to assess ambulatory care quality of other provider groups with shared responsibility for patient outcomes, such as providers in health plans, within states, and in other shared accountability arrangements.
Our measures have some limitations. First, these measures are based on claims data that may not fully capture disease severity and physical function. However, we have previously shown that provider scores on claims-based measures have good agreement with the same measures based on chart data. [33] [34] [35] [36] [37] [38] A related limitation is the concern that administrative data are vulnerable to coding intensity, wherein ACOs operating in higher utilization environments have more opportunities to document comorbid disease, increasing the severity of disease and the expected rates of admission. At the same time, health care utilization in the ambulatory care setting may also be a signal of quality; discerning these differences is an area for future research. Third, while the intention was to capture patients with all stages of disease, we needed to exclude patients with LVADs, as these patients were small in prevalence and clustered among a few ACOs, making it difficult to risk adjust. Quality measures for this group of patients are needed. Fourth, there is no gold standard to assess validity. Fifth, the outcome of admission is subject to the effects of competing mortality; however, our denominator was based on days at risk for admission with time censored if patients' died or were hospitalized.
In conclusion, we developed 2 measures of riskstandardized rates of acute hospital admissions among patients with diabetes and heart failure. These measures are consistent with consensus standards for publicly reported outcomes measures, and will incentivize ACOs to provide more efficient, coordinated, and partnered care for their patients to reduce the rates of acute, unplanned admissions. In these measures, we observed substantial variation in ACO performance, suggesting opportunities to improve care. Despite some limitations, the 2 measures of acute admission rates among patients with diabetes and heart failure are important additions to the ACO measure set.
